Nomura retains Buy ratings on Indian pharma peers
Nomura kept 'Buy' ratings on Lupin, Sun Pharmaceutical Industries, Zydus Lifesciences and Dr Reddy's Laboratories after citing strong September IPM growth; the stocks rose, with Zydus Lifesciences among gainers.